URGN · UroGen Pharma Ltd. · Executive Compensation

$35.28 +1.13 (+3.31%)

Russell 2000 member Rebalance outlook locked

Market Cap

$1.71B

48.88M

Volume · Oct 20 129.92K Avg daily vol (3M) 888.41K

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Elizabeth Barrett	Chief Executive Officer	$855,590	$774,066	$2,122,211	—	$516,263	$42,494	$4,310,624
Jason Smith	General Counsel and Chief Compliance Officer	$492,011	$198,960	$220,200	—	$197,920	$89,527	$1,198,618
Mark Schoenberg	Chief Medical Officer	$369,607	$167,500	$440,400	—	$180,000	$13,133	$1,170,640

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Elizabeth Barrett	Chief Executive Officer	$826,013	—	$2,751,111	—	$529,981	$42,753	$4,149,858
Don Kim	Former Chief Financial Officer	$363,694	—	$376,800	—	—	$623,728	$1,364,222
Jason Smith	General Counsel and Chief Compliance Officer	$475,003	—	$518,100	—	$203,179	$79,182	$1,275,464
Chris Degnan	Chief Financial Officer	$115,530	—	$176,330	$695,294	$53,125	$13,510	$1,053,789
Mark Schoenberg	Chief Medical Officer	$354,240	—	$314,000	—	$202,500	$8,145	$878,885

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Elizabeth Barrett	Chief Executive Officer	$794,243	$19,984	$2,464,250	$836,533	$479,620	$44,959	$4,639,589
Jason Smith	General Counsel and Chief Compliance Officer	$456,733	$47,984	$376,300	$267,691	$275,808	$83,663	$1,508,179
Mark Schoenberg	Chief Medical Officer	$341,469	$26,250	$519,950	$200,768	$270,000	$2,113	$1,360,550
Chris Degnan	Chief Financial Officer	—	—	—	—	—	—	—
Don Kim	Former Chief Financial Officer	—	—	—	—	—	—	—

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Elizabeth Barrett	Chief Executive Officer	$764,290	—	—	$753,195	$307,449	$45,626	$1,870,560
Jason Smith	General Counsel and Chief Compliance Officer	$440,019	$10,000	$57,900	$150,639	$198,900	$68,663	$926,121
Don Kim	Chief Financial Officer	$354,303	—	$77,200	$114,131	$148,000	$44,382	$738,016
Mark Schoenberg	Chief Medical Officer	$325,963	—	$30,880	$60,577	$180,000	$2,191	$599,610

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Elizabeth Barrett	Chief Executive Officer	$739,025	—	$882,800	$2,230,095	$315,618	$45,128	$4,212,666
Jason Smith	General Counsel and Chief Compliance Officer	$429,260	$30,000	$55,175	$296,758	$182,798	$64,680	$1,058,671
Mark Schoenberg	Chief Medical Officer	$284,907	—	$132,420	$312,213	$293,200	$1,398	$1,024,138
Molly Henderson	Former Chief Financial Officer	$434,113	—	$44,140	$267,023	$99,700	$59,782	$904,759

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Elizabeth Barrett	Chief Executive Officer	$636,987	—	$441,150	$876,164	$468,650	$43,716	$2,466,667
Jason Smith	General Counsel and Chief Compliance Officer	$126,930	$100,000	$491,500	$785,242	$92,083	$19,518	$1,615,273
Molly Henderson	Former Chief Financial Officer	$94,269	$100,000	$294,900	$787,994	$69,875	$15,192	$1,362,230
Peter Pfreundschuh	Chief Financial Officer	$324,329	$0	$176,460	$292,055	$218,800	$152,313	$1,163,956
Mark Schoenberg	Chief Medical Officer	$185,026	—	$176,460	$92,055	$293,150	$1,767	$948,458
Stephen L. Mullennix	Chief Operating Officer	$139,311	$0	$88,230	$292,055	$140,200	$246,581	$906,376

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Elizabeth Barrett	Chief Executive Officer	$694,697	$300,000	$15,082,782	$8,979,216	$840,000	$4,128	$25,900,823
Peter Pfreundschuh	Chief Financial Officer	$435,625	$0	$212,500	$436,108	$261,375	$1,183	$1,346,791
Stephen L. Mullennix	Chief Operating Officer	$435,625	$0	$212,500	$436,108	$261,375	$904	$1,346,512
Mark Schoenberg	Chief Medical Officer	$205,000	—	$106,250	$218,054	$270,000	$1,604	$800,908
Ron Bentsur	Former Chief Executive Officer	$5,812	—	—	—	—	$2,326	$8,138

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ron Bentsur	Former Chief Executive Officer	$610,200	—	—	$1,739,588	$334,000	$3,266,324	$5,950,112
Stephen L. Mullennix	Chief Operating Officer	$359,754	$70,000	$1,102,893	$2,552,946	$223,400	$575	$4,309,568
Peter Pfreundschuh	Chief Financial Officer	$156,424	$0	$527,875	$1,704,505	$96,800	$197	$2,485,800
Mark Schoenberg	Chief Medical Officer	$200,000	$0	$0	$0	$100,000	$0	$300,000

Fiscal 2017

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Ron Bentsur	Former Chief Executive Officer	$414,252	—	—	$1,244,448	$225,973	$87,667	$1,972,339
Mark Schoenberg	Chief Medical Officer	$13,636	$75,000	$490,750	$468,708	$6,030	—	$1,054,124

Executive changes

Person	Role	Change	Effective	Filed
Daniel G. Wildman	Director	Appointed	2026-06-22	2026-06-23
Leana S. Wen, M.D., M.Sc.	Director	Appointed	2026-06-22	2026-06-23
James A. Robinson, Jr.	Director	Appointed	2026-06-22	2026-06-23
Cynthia M. Butitta	Director	Appointed	2026-06-22	2026-06-23
Stuart Holden, M.D.	Director	Appointed	2026-06-22	2026-06-23
Elizabeth Barrett	Director	Appointed	2026-06-22	2026-06-23
Arie Belldegrun, M.D.	Director	Appointed	2026-06-22	2026-06-23
Leana S. Wen, M.D., M.Sc.	director	Appointed	2025-08-26	2025-08-27
Daniel G. Wildman	director	Appointed	2025-08-26	2025-08-27
Stuart Holden, M.D.	director	Appointed	2025-08-26	2025-08-27
James A. Robinson, Jr.	director	Appointed	2025-08-26	2025-08-27
Cynthia M. Butitta	director	Appointed	2025-08-26	2025-08-27
Elizabeth Barrett	director	Appointed	2025-08-26	2025-08-27
Arie Belldegrun, M.D.	director	Appointed	2025-08-26	2025-08-27
Chris Degnan	Chief Financial Officer	Appointed	2024-10-08	2024-10-09
Christopher Degnan	principal accounting officer	Appointed	2024-10-08	2024-10-09
Don Kim	director	Resigned	2024-10-08	2024-10-09
Christopher Degnan	Chief Financial Officer	Appointed	2024-10-08	2024-10-09
Don Kim	principal accounting officer	Resigned	2024-10-08	2024-10-09
Don Kim	Chief Financial Officer	Resigned	2024-10-08	2024-10-09
Fred E. Cohen, M.D., D.Phil.	director	Resigned	2024-09-12	2024-09-13
James A. Robinson, Jr.	director	Appointed	2024-08-06	2024-08-08
Daniel G. Wildman	director	Appointed	2024-08-06	2024-08-08
Leana S. Wen, M.D., M.Sc.	director	Appointed	2024-08-06	2024-08-08
Cynthia M. Butitta	director	Appointed	2024-08-06	2024-08-08

Leadership

Elizabeth Barrett CEO, Board Member
Arie Belldegrun Chairman, Board Member
Chris Degnan CFO
Dong (Don) Kim CFO
Stephen L. Mullennix COO
Jason Smith General Counsel
Christopher Degnan Chief Accounting Officer
Arie Belldegrun, M.D. Board Member
Arie Belldegrun, M.D., FACS Board Member
Cynthia M. Butitta Board Member
Daniel G. Wildman Board Member
Daniel Wildman Board Member
Fred E. Cohen, M.D. Board Member
Fred E. Cohen, M.D., D.Phil. Board Member
James A. Robinson Board Member
James A. Robinson Jr. Board Member
James A. Robinson, Jr. Board Member
Leana S. Wen Board Member
Leana S. Wen, M.D., M.Sc. Board Member
Leana Wen, M.D., MSc Board Member
Stuart Holden Board Member
Stuart Holden, M.D. Board Member

Key facts CIK 1668243 CUSIP M96088105 13F (30d) 11 filings 11 filers Visit website Investor relations